Results 101 to 110 of about 58,767 (165)

Mechanisms behind elevated serum levels of plasminogen activator inhibitor-1 in frontotemporal lobar degeneration. [PDF]

Neural Regen Res
Angelucci F, Hort J.
europepmc   +1 more source

Comment on "Role of increased plasminogen activator inhibitor-1 and vitronectin in gestational diabetes mellitus". [PDF]

Rev Assoc Med Bras (1992)
Yin H, Shi R.
europepmc   +1 more source

Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease. [PDF]

BMC Nutr
Farzin L, Mansouri E, Salehi S, Baker E, Amirkhizi F, Asghari S.   +5 more
europepmc   +1 more source

Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice. [PDF]

PLoS One
Mizukami Y, Kawao N, Ohira T, Okada K, Yamao H, Matsuo O, Kaji H.   +6 more
europepmc   +1 more source

The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction. [PDF]

Front Immunol
Yatsenko T, Rios R, Nogueira T, Salama Y, Takahashi S, Adachi E, Tabe Y, Hattori N, Osada T, Naito T, Takahashi K, Hattori K, Heissig B.   +12 more
europepmc   +1 more source

A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence. [PDF]

Cell Commun Signal
Shaikh SB, Balaya RDA, Dagamajalu S, Bhandary YP, Unwalla H, Prasad TSK, Rahman I.   +6 more
europepmc   +1 more source

Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population. [PDF]

Life (Basel)
Lomelí-Nieto JA, Muñoz-Valle JF, Navarro-Zarza JE, Baños-Hernández CJ, Gutierrez-Brito JA, Renteria-Cabrera V, Horta-Chávez EA, Morales-Núñez JJ, García-Arellano S, Parra-Rojas I, Hernández-Bello J.   +10 more
europepmc   +1 more source

Increased plasminogen activator inhibitor-1 (PAI-1) and its associations with metabolic risk in healthy young adults with early life stress. [PDF]

Psychoneuroendocrinology
Kudinova AY, Kulak MJ, Daniels TE, Angeles WLL, de la Monte S, Mathis KJ, Beck QM, Laumann LE, Tyrka AR.   +8 more
europepmc   +1 more source

Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1. [PDF]

Front Immunol
Ibrahim AA, Fujimura T, Uno T, Terada T, Hirano KI, Hosokawa H, Ohta A, Miyata T, Ando K, Yahata T.   +9 more
europepmc   +1 more source

Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis. [PDF]

Chest
Barrett CD, Moore PK, Moore EE, Moore HB, Chandler JG, Siddiqui H, Maginot ER, Sauaia A, Pérez-Calatayud AA, Buesing K, Wang J, Davila-Chapa C, Hershberger D, Douglas I, Pieracci FM, Yaffe MB.   +15 more
europepmc   +1 more source